Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117349801 | 11734980 | 1 | I | 20151102 | 20151113 | 20151113 | EXP | PHHY2015GB146106 | SANDOZ | MAKATSORI M, KIANI-ALIKHAN S, MANSON AL, VERMA N, LEANDRO M, GURUGAMA NP, ET AL.. HYPOGAMMAGLOBULINAEMIA AFTER RITUXIMAB TREATMENT-INCIDENCE AND OUTCOMES.. QJM. 2014?107 (10):821-8 | 57.00 | YR | F | Y | 0.00000 | 20151113 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117349801 | 11734980 | 1 | PS | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | Unknown | 22137 | |||||||||||
| 117349801 | 11734980 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | 0 | |||||||||||
| 117349801 | 11734980 | 3 | SS | CHLORAMBUCIL | CHLORAMBUCIL | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117349801 | 11734980 | 1 | Lymphoma |
| 117349801 | 11734980 | 2 | Lymphoma |
| 117349801 | 11734980 | 3 | Lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117349801 | 11734980 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117349801 | 11734980 | Hypogammaglobulinaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |